Quantcast
Channel: GenomeWeb - circulating tumor DNA
Browsing all 139 articles
Browse latest View live
↧

C2i Genomics Raises $12M in Series A Financing

View Article


Liquid Biopsy Startup C2i Genomics to Launch International Validation Trials...

View Article


ArcherDX, Bristol Myers Squibb Partner on Minimal Residual Disease Monitoring

View Article

Science Studies Describe Approach to Improve Detection of Circulating Tumor...

View Article

Patient-Specific ctDNA Detection Method Could Improve MRD Monitoring for...

View Article


Inivata Demonstrates Potential of ctDNA Assay for Cancer Recurrence, MRD...

View Article

Brain and Kidney Cancer Studies Lay Path for Clinical Application of...

View Article

PNAS Papers on Small Molecule From Soil Bacteria, Circulating Tumor Cell...

View Article


Guardant Health to Develop Liquid Biopsy Companion Diagnostic for Janssen...

View Article


Payor Policy Study Reveals Progress, Challenges in Liquid Biopsy Reimbursement

View Article

Presence of cfDNA, CTCs Predicts Recurrence in Triple-Negative Breast Cancer

View Article

Canadian Consortium Launches C$2.6M Liquid Biopsy Initiative to Improve...

View Article

Saga Diagnostics, SensID to Codevelop Control Reagents for Cancer Mutation...

View Article


Thrive Earlier Detection Raises $257M in Series B Financing

View Article

Guardant Health Enters CDx Collaboration With Radius Health for Elacestrant...

View Article


Natera's Signatera ctDNA Test Shows Immunotherapy Response Prediction...

View Article

Guardant Health Q2 Revenues Rise 23 Percent

View Article


Guardant Health CDx Wins FDA Approval for First Liquid Biopsy NGS Tumor...

View Article

Guardant Health Colorectal Cancer Early-Detection Test Progresses Despite...

View Article

Genosity Latest Entrant to Growing ctDNA Residual Disease Monitoring Market

View Article
Browsing all 139 articles
Browse latest View live